Home » Topics » Regulatory

Regulatory
RSS

Rebif launched in Canada: first drug to delay disease progression in remitting-relapsing MS

Feb. 20, 1998

New octreotide formulation launched in Italy

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

New formulation of FK-506 demonstrates superior efficacy

Feb. 17, 1998

IND approved for new formulation of lidocaine

Feb. 17, 1998

CellCept evaluated in the clinic for another new indication

Feb. 17, 1998

Micronized fenofibrate receives FDA approval

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...